These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 24021366

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Carnitine: a therapeutic option for childhood psoriatic onycho-pachydermo-periostitis (POPP).
    Fietta P, Manganelli P.
    Clin Rheumatol; 2007 Jan; 26(1):93-4. PubMed ID: 16738841
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Psoriatic onycho-pachydermo-periostitis successfully treated with low-dose methotrexate.
    Ochiai T, Washio H, Shiraiwa H, Takei M, Sawada S.
    Med Sci Monit; 2006 Apr; 12(4):CS27-30. PubMed ID: 16572055
    [Abstract] [Full Text] [Related]

  • 6. Psoriatic onycho-pachydermo periostitis.
    Srivastava M, Solomon G, Strober B.
    Dermatol Online J; 2007 Jan 27; 13(1):20. PubMed ID: 17511953
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential effect of etanercept on cutaneous and joint lesions in psoriatic arthritis.
    Mizote Y, Nakahara T, Mitoma C, Nakao M, Mitoma H, Moroi Y, Furue M.
    J Dermatol; 2012 Mar 27; 39(3):284-5. PubMed ID: 21950550
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study.
    de Vlam K, Lories RJ.
    Rheumatology (Oxford); 2006 Mar 27; 45(3):321-4. PubMed ID: 16234275
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Nail psoriasis--an ignored disorder. Pathogenesis, diagnosis and therapy].
    Kahl C, Hansen B, Reich K.
    Hautarzt; 2012 Mar 27; 63(3):184-91. PubMed ID: 22382303
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of adalimumab, etanercept, and infliximab in psoriatic arthritis based on ACR50 response after 24 weeks of treatment.
    Brodszky V, Pentek M, Gulacsi L.
    Scand J Rheumatol; 2008 Mar 27; 37(5):399-400. PubMed ID: 18821278
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Psoriatic onycho-pachydermo periostitis (POPP): a case report treated successfully with IL-17 blockade and a literature review on characteristics, pathogenesis, and treatment.
    Sakellariou GT, Tsifountoudis I, Vounotrypidis P.
    Clin Rheumatol; 2021 Nov 27; 40(11):4749-4757. PubMed ID: 33830360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.